Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

BlueRock Therapeutics Stock

bluerocktx.comHealthcareFounded: 2016Funding to Date: $225MM

BlueRock Therapeutics is an engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases with a platform that harnesses the power of cells for new medicines across neurology, cardiology and autoimmune indications.

Learn more about BlueRock Therapeutics IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for BlueRock Therapeutics.

Register Today

Team

Management Team

Emile Nuwaysir Ph.D

Chief Executive Officer, President & Board Member

Gordon Keller Ph.D

Scientific Co-Founder

Shane Kovacs

Chief Business and Financial Officer

Min Wang Ph.D

Chief Administrative & Legal Officer

Lorenz Studer Ph.D

Scientific Co-Founder

Robert Deans Ph.D

Chief Technology Officer

Joachim Fruebis Ph.D

Chief Development Officer

Michael Scott Ph.D

Senior Vice President, Product Development

Board Members

Bradley Bolzon Ph.D

Versant Venture Management

Jerel Davis Ph.D

Versant Venture Management

Jurg Eckardt MD

Axel Bouchon

Other companies like BlueRock Therapeutics in the Healthcare sector

Sector

Last Round Est. Valuation

$2.15B

Colossal Biosciences

Sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$400.53MM

Sector

Last Round Est. Valuation

$4.26B

Sector

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Sector

Precision Neuroscience

Sector

Frequently Asked Questions